osilodrostat 1 MG Oral Tablet [Isturisa]
- RxCUI
- 2286281
- RxNorm name
- osilodrostat 1 MG Oral Tablet [Isturisa]
- Display name
- osilodrostat 1 MG Oral Tablet [Isturisa]
- Full name
- osilodrostat 1 MG Oral Tablet [Isturisa]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isturisa | OSILODROSTAT | Recordati Rare Diseases, Inc. | f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2 | 2025-11-18 | Warnings, Adverse reactions | 2286281 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2 | Isturisa 1 MG Oral Tablet [PSN] · osilodrostat 1 MG Oral Tablet [Isturisa] [SBD] · Isturisa 1 MG (as osilodrostat phosphate 1.4 MG) Oral Tablet [SY] · Isturisa 1 MG Oral Tablet [SY] | 4 | 10 | These highlights do not include all the information needed to use ISTURISA ® safely and effectively. See full prescribing information for ISTURISA. ISTURISA (osilodrostat) tablets, for oral use Initial U.S. Approval: 2020 | 20251118 |